AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
133.49B
HNCCX
Price
$18.00
Change
+$0.14 (+0.78%)
Updated
Sep 5 closing price
Net Assets
342.14M
Interact to see
Advertisement

AEPCX vs HNCCX

Header iconAEPCX vs HNCCX Comparison
Open Charts AEPCX vs HNCCXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets133.49B
Hartford International Growth C
Price$18.00
Change+$0.14 (+0.78%)
VolumeN/A
Net Assets342.14M
AEPCX vs HNCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. HNCCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and HNCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. HNCCX (342M). AEPCX pays higher dividends than HNCCX: AEPCX (0.16) vs HNCCX (0.00). AEPCX was incepted earlier than HNCCX: AEPCX (25 years) vs HNCCX (24 years). HNCCX (2.14) is less costly to investors than AEPCX (1.57). AEPCX is a more actively managed with annual turnover of: 35.00 vs. HNCCX (31.00). AEPCX has a lower initial minimum investment than HNCCX: AEPCX (250) vs HNCCX (2000). HNCCX annual gain was more profitable for investors over the last year : 18.73 vs. AEPCX (7.59). HNCCX return over 5 years is better than : 22.28 vs. AEPCX (7.78).
AEPCXHNCCXAEPCX / HNCCX
Total Expense Ratio1.572.0577%
Annual Report Gross Expense Ratio1.572.1473%
Fund Existence25 years24 years-
Gain YTD15.03818.81280%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets133B342M38,889%
Annual Yield % from dividends0.160.00-
Returns for 1 year7.5918.7341%
Returns for 3 years32.6560.1454%
Returns for 5 years7.7822.2835%
Returns for 10 years34.3464.3353%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX39.570.50
+1.28%
Eventide Healthcare & Life Sciences N
CGFAX84.690.20
+0.24%
American Funds Growth Fund of Amer 529A
FRAAX60.81N/A
N/A
Franklin Growth Opportunities Adv
DNLDX64.61-0.01
-0.02%
BNY Mellon Active MidCap A
MIIOX30.51-0.02
-0.07%
Marsico International Opportunities Inst